Real-Life Effectiveness and Safety of Glecaprevir/Pibrentasvir for Korean Patients with Chronic Hepatitis C at a Single Institution

BACKGROUND/AIMS: Glecaprevir/pibrentasvir (G/P) is a combination of direct-acting antiviral agents that is an approved treatment for chronic infections by all six hepatitis C virus (HCV) genotypes. However, there are limited data on the effect of G/P in Korean patients in actual real-world settings....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Gut Liver
Autors principals: Park, Young Joo, Woo, Hyun Young, Heo, Jeong, Park, Sang Gyu, Hong, Young Mi, Yoon, Ki Tae, Kim, Dong Uk, Kim, Gwang Ha, Kim, Hyung Hoi, Song, Geun Am, Cho, Mong
Format: Artigo
Idioma:Inglês
Publicat: Editorial Office of Gut and Liver 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8129668/
https://ncbi.nlm.nih.gov/pubmed/32839365
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5009/gnl19393
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars